Clinical Trial Update: Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse [Phase 4]

View source ↗

Summary

Completion report for a Phase 4 trial evaluating atomoxetine in adults with ADHD and comorbid alcohol use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Eli Lilly and Company | Conditions: ADHD, Comorbid Alcohol Abuse | Phase 4 | Status: COMPLETED